- Collagen Solutions' trading in the year to the end of March has exceeded previous guidance.

And the group has announced leadership changes with Jamal D. Rushdy appointed as chief executive with founder Dr. Stewart White becoming chief scientific officer, both with immediate effect.

Rushdy's initial appointment as chief business officer was announced in November 2015. He has over 20 years' experience in the medical device arena, specifically within two mid-size high growth public companies and three successful start-ups. He has a track record of building businesses with successful exits and transforming organisations through integration and performance improvement, adding value through business development and leadership. White now leads R&D and corporate development and will focus on the company's product development and innovation platform while also realising value from innovative technologies such as the ChondroMimetic portfolio of assets.

The company also announced preliminary revenue, including other income, of GBP3.2 million for the year ending 31 March 2016, which exceeds prior guidance of GBP2.8 million. These results have been in part driven by the early benefits of the company's implementation of an improved sales process, together with achievement of global sales and integration synergies. The Company now has dedicated sales people in Europe, Asia, and North America.

At 8:06am: [LON:COS] COLLAGEN SOLUTIONS ORD 1P share price was +0.38p at 6.75p

Story provided by